(Q34699002)

4 August 2017

1 reference

title

Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. (English)

1 reference

chronic inflammatory demyelinating polyradiculoneuropathy

4 August 2017

main subject

0 references

author name string

I N Van Schaik

1

1 reference

4 August 2017

J B Winer

2

1 reference

4 August 2017

R De Haan

3

1 reference

4 August 2017

M Vermeulen

4

1 reference

4 August 2017

publication date

1 January 2002

1 reference

Cochrane Database of Systematic Reviews

4 August 2017

published in

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

CD001797

1 reference

A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy.

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

An "n of 1" trial of intravenous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Measuring quality of life in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

The Rochester Diabetic Neuropathy Study: Reassessment of tests and criteria for diagnosis and staged severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

High-dose intravenous human immunoglobulin in chronic inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Liver transplantation in a Jehovah's witness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Early or deferred zidovudine therapy in HIV-infected patients without an AIDS-defining illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Treatment approaches for Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

A critical review of therapies in acute and chronic inflammatory demyelinating polyneuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Future developments in the treatment of immune-mediated polyneuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

On the mechanism of high-dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Clinical and laboratory characteristics associated with improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

In vitro effects of polyvalent immunoglobulin for intravenous use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Ocular palsy preceding chronic relapsing polyneuropathy by several weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

The treatment of chronic relapsing and chronic progressive idiopathic inflammatory polyneuropathy by plasma exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Chronic inflammatory demyelinating polyneuropathy: histological and immunopathological studies on biopsied sural nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Impact of neurologic signs and symptoms on functional status in peripheral neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Treatment of chronic relapsing inflammatory polyradiculoneuropathy by plasma exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Chronic inflammatory demyelinating polyneuropathy. Conduction failure before and during immunoglobulin or plasma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001797

10.1002/14651858.CD001797

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference